RECOMBINA Competitors and Similar CompaniesClear all
EV Biotech's competitors and similar companies include Thousand Oaks Biopharmaceuticals and ReCode Therapeutics.
 EV Biotech EV Biotech is a company specializing in the biological production of chemical compounds for flavors and fragrances, biomaterials, agriculture, and pharmaceutical markets. |  Thousand Oaks Biopharmaceuticals Thousand Oaks Biopharmaceuticals (澳斯康生物制药) is a company that provides contract research and manufacturing services with a focus on cell line development. |  ReCode Therapeutics ReCode Therapeutics is a company developing non-viral nanoparticles for delivery of diverse RNA- and protein-based therapeutics to targeted tissues, and tRNA NanoCorrectors. | |
Founding Date | Founding Date 2018 | Founding Date 2017 | Founding Date 2015 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations Groningen, NL HQ | Locations Nantong, CN HQ | Locations Menlo Park, US HQ |
Employees | Employees 6 | Employees 43 | Employees 1062% decrease |
Funding | |||
Latest funding round | Latest funding round $ 1.3m (almost 8 years ago) | Latest funding round $ 64m (almost 6 years ago) | Latest funding round $ 80m (about 6 years ago) |
Total funding raised | Total funding raised $ 1.3m | Total funding raised $ 107.6m | Total funding raised $ 82m |
For sources of this data, please see the company profile
View Company Profiles
Thousand Oaks Biopharmaceuticals
HQ
Nantong, CN
Employees
43
Thousand Oaks Biopharmaceuticals (澳斯康生物制药) is a company that provides contract research and manufacturing services with a focus on cell line development.
View companyReCode Therapeutics
HQ
Menlo Park, US
Employees
106↓ 2% decrease
ReCode Therapeutics is a company developing non-viral nanoparticles for delivery of diverse RNA- and protein-based therapeutics to targeted tissues, and tRNA NanoCorrectors.
View company